Table 1

Descriptive statistics of participants

Participants’ characteristics (n=200)
Population demographics
Age, median (IQR), (years)51 (40–57)
Sex (male/female)121 (61)/79 (39)
Height, mean (SD), (cm)179.2 (9.3)
BMI, median (IQR), (kg/m2)25.4 (23.5–28.8)
Tendinopathy descriptors
AT (unilateral/bilateral)132 (66)/68 (34)
Symptom duration, median (IQR), (weeks)94 (39–213)
VISA-A score at baseline (0–100), mean (SD)45.3 (18.7)
Pain location (midportion/insertion)106 (53)/94 (47)
General health and comorbidities
Sports participation (yes/no)183 (92)/17 (8)
AAS score (0–10), median (IQR)4 (4–7)
Sport adaptation (none/reduced/stopped)32 (16)/42 (21)/126 (63)
Prior history of tendinopathy (yes/no)92 (46)/108 (54)
Medication use (yes/no)70 (35)/130 (65)
Comorbidities* (yes/no)54 (27)/146 (73)
  • Data are presented as No. (%) unless otherwise specified. Sports adaptation: patients who reported no change in sports activities, a reduction in sports activities or stopped performing sports activities.

  • *Comorbidities included diabetes, hypercholesterolaemia, hypertension, heart/vessel diseases, uveitis, (inflammatory) bowel disease, rheumatism, thyroid disease and psoriasis.

  • AAS, Ankle Activity Score; AT, Achilles tendinopathy; BMI, body mass index; VISA-A, Victorian Institute of Sport Assessment Achilles.